Circadian disruption-induced microRNAome deregulation in rat mammary gland tissues

Oncoscience

Volumn 2, Issue 4, 2015, Pages 428-442

  Kochan, David Z ^a   Ilnytskyy, Yaroslav ^a   Golubov, Andrey ^a   Deibel, Scott H ^b   McDonald, Robert J ^b   Kovalchuk, Olga ^a  

^a UNIVERSITY OF LETHBRIDGE   (Canada)

^b UNIVERSITY OF LETHBRIDGE   (Canada)

Author keywords

Breast cancer; Circadian disruption (CD); Epigenetics; MicroRNA (miRNA)

Indexed keywords

EID: 84958554211     PISSN: None     EISSN: 23314737     Source Type: Journal    
DOI: 10.18632/oncoscience.157     Document Type: Article

References (61)

1. Hansen J and Stevens RG. Case-control study of shift-work and breast cancer risk in Danish nurses: impact of shift systems. European journal of cancer. 2012; 48:1722-1729.
2. Blask DE, Dauchy RT, Sauer LA, Krause JA and Brainard GC. Growth and fatty acid metabolism of human breast cancer (MCF-7) xenografts in nude rats: impact of constant light-induced nocturnal melatonin suppression. Breast cancer research and treatment. 2003; 79:313-320.
3. Cos S, Mediavilla D, Martinez-Campa C, Gonzalez A, Alonso-Gonzalez C and Sanchez-Barcelo EJ. Exposure to light-at-night increases the growth of DMBA-induced mammary adenocarcinomas in rats. Cancer letters. 2006; 235:266-271.
4. Haus EL and Smolensky MH. Shift work and cancer risk: potential mechanistic roles of circadian disruption, light at night, and sleep deprivation. Sleep medicine reviews. 2013; 17:273-284.
5. Knutsson A, Alfredsson L, Karlsson B, Akerstedt T, Fransson EI, Westerholm P and Westerlund H. Breast cancer among shift workers: results of the WOLF longitudinal cohort study. Scandinavian journal of work, environment & health. 2013; 39:170-177.
6. Jovanovic J, Ronneberg JA, Tost J and Kristensen V. The epigenetics of breast cancer. Molecular oncology. 2010; 4:242-254.
7. Koturbash I, Zemp FJ, Pogribny I and Kovalchuk O. Small molecules with big effects: the role of the microRNAome in cancer and carcinogenesis. Mutation research. 2011; 722:94-105.
8. Pegoraro M and Tauber E. The role of microRNAs (miRNA) in circadian rhythmicity. Journal of genetics. 2008; 87:505-511.
9. Hwang HW and Mendell JT. MicroRNAs in cell proliferation, cell death, and tumorigenesis. British journal of cancer. 2006; 94:776-780.
10. Sire C, Moreno AB, Garcia-Chapa M, Lopez-Moya JJ and San Segundo B. Diurnal oscillation in the accumulation of Arabidopsis microRNAs, miR167, miR168, miR171 and miR398. FEBS letters. 2009; 583:1039-1044.
11. Nagel R, Clijsters L and Agami R. The miRNA-192/194 cluster regulates the Period gene family and the circadian clock. The FEBS journal. 2009; 276:5447-5455.
12. Alvarez-Saavedra M, Antoun G, Yanagiya A, Oliva-Hernandez R, Cornejo-Palma D, Perez-Iratxeta C, Sonenberg N and Cheng HY. miRNA-132 orchestrates chromatin remodeling and translational control of the circadian clock. Human molecular genetics. 2011; 20:731-751.
13. Zhang ZG, Chen WX, Wu YH, Liang HF and Zhang BX. MiR-132 prohibits proliferation, invasion, migration, and metastasis in breast cancer by targeting HN1. Biochemical and biophysical research communications. 2014; 454:109-114.
14. Jacobs DI, Hansen J, Fu A, Stevens RG, Tjonneland A, Vogel UB, Zheng T and Zhu Y. Methylation alterations at imprinted genes detected among long-term shiftworkers. Environmental and molecular mutagenesis. 2013; 54:141-146.
15. Schwimmer H, Metzer A, Pilosof Y, Szyf M, Machnes ZM, Fares F, Harel O and Haim A. Light at night and melatonin have opposite effects on breast cancer tumors in mice assessed by growth rates and global DNA methylation. Chronobiology international. 2014; 31:144-150.
16. Zhu Y, Stevens RG, Hoffman AE, Tjonneland A, Vogel UB, Zheng T and Hansen J. Epigenetic impact of long-term shiftwork: pilot evidence from circadian genes and wholegenome methylation analysis. Chronobiology international. 2011; 28:852-861.
17. Liu R, Jacobs DI, Hansen J, Fu A, Stevens RG and Zhu Y. Aberrant methylation of miR-34b is associated with longterm shiftwork: a potential mechanism for increased breast cancer susceptibility. Cancer causes & control: CCC. 2015; 26:171-178.
18. Shi F, Chen X, Fu A, Hansen J, Stevens R, Tjonneland A, Vogel UB, Zheng T and Zhu Y. Aberrant DNA methylation of miR-219 promoter in long-term night shiftworkers. Environmental and molecular mutagenesis. 2013; 54:406-413.
19. Git A, Dvinge H, Salmon-Divon M, Osborne M, Kutter C, Hadfield J, Bertone P and Caldas C. Systematic comparison of microarray profiling, real-time PCR, and next-generation sequencing technologies for measuring differential microRNA expression. Rna. 2010; 16:991-1006.
20. Craig LA and McDonald RJ. Chronic disruption of circadian rhythms impairs hippocampal memory in the rat. Brain research bulletin. 2008; 76:141-151.
21. Deibel SH, Hong NS, Himmler SM and McDonald RJ. The effects of chronic photoperiod shifting on the physiology of female Long-Evans rats. Brain research bulletin. 2014; 103:72-81.
22. Devan BD, Goad EH, Petri HL, Antoniadis EA, Hong NS, Ko CH, Leblanc L, Lebovic SS, Lo Q, Ralph MR and McDonald RJ. Circadian phase-shifted rats show normal acquisition but impaired long-term retention of place information in the water task. Neurobiology of learning and memory. 2001; 75:51-62.
23. McDonald RJ, Zelinski EL, Keeley RJ, Sutherland D, Fehr L and Hong NS. Multiple effects of circadian dysfunction induced by photoperiod shifts: alterations in context memory and food metabolism in the same subjects. Physiology & behavior. 2013; 118:14-24.
24. Azzi A, Dallmann R, Casserly A, Rehrauer H, Patrignani A, Maier B, Kramer A and Brown SA. Circadian behavior is light-reprogrammed by plastic DNA methylation. Nature neuroscience. 2014; 17:377-382.
25. Na YJ, Sung JH, Lee SC, Lee YJ, Choi YJ, Park WY, Shin HS and Kim JH. Comprehensive analysis of microRNAmRNA co-expression in circadian rhythm. Experimental & molecular medicine. 2009; 41:638-647.
26. Blask DE. Melatonin, sleep disturbance and cancer risk. Sleep medicine reviews. 2009; 13:257-264.
27. Reiter RJ. Mechanisms of cancer inhibition by melatonin. Journal of pineal research. 2004; 37:213-214.
28. Cui W, Zhang S, Shan C, Zhou L and Zhou Z. microRNA-133a regulates the cell cycle and proliferation of breast cancer cells by targeting epidermal growth factor receptor through the EGFR/Akt signaling pathway. The FEBS journal. 2013; 280:3962-3974.
29. Nohata N, Hanazawa T, Enokida H and Seki N. microRNA-1/133a and microRNA-206/133b clusters: dysregulation and functional roles in human cancers. Oncotarget. 2012; 3:9-21.
30. Hoffman AE, Yi CH, Zheng T, Stevens RG, Leaderer D, Zhang Y, Holford TR, Hansen J, Paulson J and Zhu Y. CLOCK in breast tumorigenesis: genetic, epigenetic, and transcriptional profiling analyses. Cancer research. 2010; 70:1459-1468.
31. Fu A, Leaderer D, Zheng T, Hoffman AE, Stevens RG and Zhu Y. Genetic and epigenetic associations of circadian gene TIMELESS and breast cancer risk. Molecular carcinogenesis. 2012; 51:923-929.
32. Mao Y, Fu A, Leaderer D, Zheng T, Chen K and Zhu Y. Potential cancer-related role of circadian gene TIMELESS suggested by expression profiling and in vitro analyses. BMC cancer. 2013; 13:498.
33. Bhaumik D, Scott GK, Schokrpur S, Patil CK, Campisi J and Benz CC. Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells. Oncogene. 2008; 27:5643-5647.
34. Walker SR, Xiang M and Frank DA. STAT3 Activity and Function in Cancer: Modulation by STAT5 and miR-146b. Cancers. 2014; 6:958-968.
35. Helbig G, Christopherson KW, 2nd, Bhat-Nakshatri P, Kumar S, Kishimoto H, Miller KD, Broxmeyer HE and Nakshatri H. NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4. The Journal of biological chemistry. 2003; 278:21631-21638.
36. Hoesel B and Schmid JA. The complexity of NF-kappaB signaling in inflammation and cancer. Molecular cancer. 2013; 12:86.
37. Shostak K and Chariot A. NF-kappaB, stem cells and breast cancer: the links get stronger. Breast cancer research: BCR. 2011; 13:214.
38. Kendellen MF, Bradford JW, Lawrence CL, Clark KS and Baldwin AS. Canonical and non-canonical NF-kappaB signaling promotes breast cancer tumor-initiating cells. Oncogene. 2014; 33:1297-1305.
39. Campisi J. Aging, cellular senescence, and cancer. Annual review of physiology. 2013; 75:685-705.
40. Pan C, Chen H, Wang L, Yang S, Fu H, Zheng Y, Miao M and Jiao B. Down-regulation of MiR-127 facilitates hepatocyte proliferation during rat liver regeneration. PloS one. 2012; 7:e39151.
41. Wang M, Cheng Z, Tian T, Chen J, Dou F, Guo M and Cong YS. Differential expression of oncogenic miRNAs in proliferating and senescent human fibroblasts. Molecular and cellular biochemistry. 2011; 352:271-279.
42. Rodier F and Campisi J. Four faces of cellular senescence. The Journal of cell biology. 2011; 192(4):547-556.
43. Chen J, Wang M, Guo M, Xie Y and Cong YS. miR-127 regulates cell proliferation and senescence by targeting BCL6. PloS one. 2013; 8:e80266.
44. Shvarts A, Brummelkamp TR, Scheeren F, Koh E, Daley GQ, Spits H and Bernards R. A senescence rescue screen identifies BCL6 as an inhibitor of anti-proliferative p19(ARF)-p53 signaling. Genes & development. 2002; 16:681-686.
45. Blanco MA, Aleckovic M, Hua Y, Li T, Wei Y, Xu Z, Cristea IM and Kang Y. Identification of staphylococcal nuclease domain-containing 1 (SND1) as a Metadherin-interacting protein with metastasis-promoting functions. The Journal of biological chemistry. 2011; 286:19982-19992.
46. Kuruma H, Kamata Y, Takahashi H, Igarashi K, Kimura T, Miki K, Miki J, Sasaki H, Hayashi N and Egawa S. Staphylococcal nuclease domain-containing protein 1 as a potential tissue marker for prostate cancer. The American journal of pathology. 2009; 174:2044-2050.
47. Scadden AD. The RISC subunit Tudor-SN binds to hyperedited double-stranded RNA and promotes its cleavage. Nature structural & molecular biology. 2005; 12:489-496.
48. Yang W, Chendrimada TP, Wang Q, Higuchi M, Seeburg PH, Shiekhattar R and Nishikura K. Modulation of microRNA processing and expression through RNA editing by ADAR deaminases. Nature structural & molecular biology. 2006; 13:13-21.
49. Armengol S, Arretxe E, Rodriguez L, Ochoa B, Chico Y and Martinez MJ. NF-kappaB, Sp1 and NF-Y as transcriptional regulators of human SND1 gene. Biochimie. 2013; 95:735-742.
50. Zhao X, Duan Z, Liu X, Wang B, Wang X, He J, Yao Z and Yang J. MicroRNA-127 is downregulated by Tudor-SN protein and contributes to metastasis and proliferation in breast cancer cell line MDA-MB-231. Anatomical record. 2013; 296:1842-1849.
51. Chung SS, Giehl N, Wu Y and Vadgama JV. STAT3 activation in HER2-overexpressing breast cancer promotes epithelial-mesenchymal transition and cancer stem cell traits. International journal of oncology. 2014; 44:403-411.
52. Siveen KS, Sikka S, Surana R, Dai X, Zhang J, Kumar AP, Tan BK, Sethi G and Bishayee A. Targeting the STAT3 signaling pathway in cancer: role of synthetic and natural inhibitors. Biochimica et biophysica acta. 2014; 1845:136-154.
53. Xiang M, Birkbak NJ, Vafaizadeh V, Walker SR, Yeh JE, Liu S, Kroll Y, Boldin M, Taganov K, Groner B, Richardson AL and Frank DA. STAT3 induction of miR-146b forms a feedback loop to inhibit the NF-kappaB to IL-6 signaling axis and STAT3-driven cancer phenotypes. Science signaling. 2014; 7:ra11.
54. Etoh T, Kanai Y, Ushijima S, Nakagawa T, Nakanishi Y, Sasako M, Kitano S and Hirohashi S. Increased DNA methyltransferase 1 (DNMT1) protein expression correlates significantly with poorer tumor differentiation and frequent DNA hypermethylation of multiple CpG islands in gastric cancers. The American journal of pathology. 2004; 164:689-699.
55. Walker SR, Nelson EA, Yeh JE, Pinello L, Yuan GC and Frank DA. STAT5 outcompetes STAT3 to regulate the expression of the oncogenic transcriptional modulator BCL6. Molecular and cellular biology. 2013; 33:2879-2890.
56. Emde AK, Grunert M, Weese D, Reinert K and Sperling SR. MicroRazerS: rapid alignment of small RNA reads. Bioinformatics (Oxford, England). 2010; 26:123-124.
57. Davoren PA, McNeill RE, Lowery AJ, Kerin MJ and Miller N. Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer. BMC molecular biology. 2008; 9:76.
58. Wang Y, Tang N, Hui T, Wang S, Zeng X, Li H and Ma J. Identification of endogenous reference genes for RTqPCR analysis of plasma microRNAs levels in rats with acetaminophen-induced hepatotoxicity. Journal of applied toxicology: JAT. 2013; 33:1330-1336.
59. Kovalchuk O, Filkowski J, Meservy J, Ilnytskyy Y, Tryndyak VP, Chekhun VF and Pogribny IP. Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin. Molecular cancer therapeutics. 2008; 7:2152-2159.
60. Anders S and Huber W. Differential expression analysis for sequence count data. Genome biology. 2010; 11:R106.
61. Benjamini Y and Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society Series B (Methodological). 1995; 57:289-300.